Predict your next investment

i2n company logo
BUSINESS PRODUCTS & SERVICES | Consulting & Outsourcing / Management & Strategy Consulting

See what CB Insights has to offer

About i2n

i2n (Ideas x Innovation Network) supports emerging growth businesses throughout their entire life cycle by leveraging the assets of academic institutions and partners. It is based in Exton, Pennsylvania.

i2n Headquarter Location

737 Constitution Drive

Exton, Pennsylvania, 19341,

United States

Latest i2n News

NPS acquires EMIS eye screening businesses

Apr 2, 2019

Public sector software and services specialist Northgate Public Services (NPS) has acquired the eye screening businesses of EMIS Group for a total cash consideration of £14.9m. The deal follows the acquisition of APD Communications in January 2019 and i2N in August 2018. The acquisition comprises: Medical Imaging UK Ltd (England eye screening services), MIDRSS Ltd (Ireland eye screening services) and Digital Healthcare Ltd (eye screening software). These three businesses formed the Specialist & Care segment of EMIS Group, which in the financial year ended 31 December 2018 achieved revenue of £20.4m, up 13% on the previous year, and an adjusted operating profit of £1.1m (see EMIS grows despite legacy distractions ). The largest of these businesses is Medical Imaging UK, which had revenues of £14.6m in 2017. Digital Healthcare is a smaller business (2017: £2.2m) but its software holds a dominant position with an estimated 74% market share in English diabetic retinopathy screening in 2018. EMIS will use the proceeds of the disposal to invest in its plans to re-energise growth, including improving service performance and efficiency, growing its private sector enterprise business, and accelerating its technology roadmap. The deal significantly bolsters NPS’ presence in healthcare screening, which includes supporting Scotland’s Diabetic Screening Programme and the Newborn Hearing Screening Program in England and Northern Ireland. The acquisition will triple its healthcare revenue, will strengthen its Screening for Health software platform, and add a nationwide base of professional screening staff. In our recently published UK Public Sector Prospects report we said there was greater opportunity for NPS in healthcare and that it was an area it should be prioritising in its acquisition strategy. It has now done this, and it puts NPS in a strong position for future screening programmes in the UK and Ireland. We also expect NPS to look to build on their recent Indian Joint Registry and Paediatric screening deals by adding diabetic retinopathy screening capability.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

i2n Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

i2n Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.